BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B
BiohacksAI/Targets/SBK1/Compounds

Compounds That Target SBK1

SH3 domain binding kinase 1 · 13 compounds in BiohacksAI corpus

SBK1 (SH3 domain binding kinase 1) is a biological target with 13 documented compound interactions in the BiohacksAI corpus. The compounds listed below have been identified through computational analysis of BindingDB binding assay data and PubMed literature. Each interaction is ranked by confidence score reflecting the breadth and strength of experimental evidence. This resource supports research into SBK1 modulation for therapeutic and biohacking applications.

View SBK1 target page →UniProt: Q52WX2 ↗
Most Studied Compounds for SBK1
1
Crizotinib
298+
studies
2
Afatinib
297+
studies
All 13 Compounds — Ranked by Evidence
1
Gefitinib
5.67
confidence
2
Erlotinib
5.55
confidence
3
Ruxolitinib
4.23
confidence
4
Nintedanib
3.61
confidence
5
Tae 684
3.43
confidence
6
Fedratinib
3.40
confidence
7
Dovitinib
3.09
confidence
8
Lestaurtinib
3.04
confidence
9
R 406
2.83
confidence
10
Kw 2449
2.64
confidence
11
Su 014813
2.20
confidence
12
Afatinib
297+
studies
0.69
confidence
13
Crizotinib
298+
studies
0.69
confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for SBK1 (SH3 domain binding kinase 1). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: SBK1 target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.